UBS Group AG vs Vertex Pharmaceuticals Incorporated

Vergleich der Marktkapitalisierung im Zeitverlauf

UBS Group AG

$131.4B

Rang #126

Vertex Pharmaceuticals Incorporated

$132.8B

Rang #123

Marktkapitalisierung im Zeitverlauf

Jahr	UBS Group AG	Vertex Pharmaceuticals Incorporated	Spitzenreiter
2026	$131.4B	$132.8B	Vertex Pharmaceuticals Incorporated
2025	$131.3B	$115.1B	UBS Group AG
2024	$94.7B	$102.2B	Vertex Pharmaceuticals Incorporated
2023	$86.7B	$103.3B	Vertex Pharmaceuticals Incorporated
2022	$55.5B	$73.3B	Vertex Pharmaceuticals Incorporated
2021	$51.4B	$55.7B	Vertex Pharmaceuticals Incorporated
2020	$38.1B	$60.0B	Vertex Pharmaceuticals Incorporated
2019	$35.0B	$55.6B	Vertex Pharmaceuticals Incorporated
2018	$33.2B	$42.1B	Vertex Pharmaceuticals Incorporated
2017	$46.8B	$38.0B	UBS Group AG
2016	$41.6B	$18.7B	UBS Group AG
2015	$48.1B	$31.9B	UBS Group AG
2014	$40.5B	$30.2B	UBS Group AG
2013	$39.6B	$18.9B	UBS Group AG
2012	$32.4B	$10.6B	UBS Group AG
2011	$25.2B	$8.4B	UBS Group AG
2010	$34.5B	$8.9B	UBS Group AG
2009	$36.7B	$10.9B	UBS Group AG
2008	$33.4B	$7.7B	UBS Group AG
2007	$117.9B	$5.9B	UBS Group AG
2006	$161.9B	$9.5B	UBS Group AG
2005	$136.7B	$7.0B	UBS Group AG
2004	$104.2B	$2.7B	UBS Group AG
2003	$92.6B	$2.6B	UBS Group AG
2002	$73.5B	$4.0B	UBS Group AG
2001	$91.6B	$6.2B	UBS Group AG
2000	$95.7B	$18.1B	UBS Group AG
1999	$77.8B	$4.4B	UBS Group AG
1998	$76.4B	$3.8B	UBS Group AG
1997	$76.2B	$4.2B	UBS Group AG
1996	$42.6B	$5.1B	UBS Group AG
1995	$47.6B	$3.4B	UBS Group AG